The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

被引:33
作者
Soave, Armin
John, Lisa-Marie
Dahlem, Roland
Minner, Sarah
Engel, Oliver
Schmidt, Selina
Kluth, Luis A.
Fisch, Margit
Rink, Michael [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany
关键词
TRANSITIONAL-CELL-CARCINOMA; CANCER-SPECIFIC MORTALITY; UPPER URINARY-TRACT; PROGNOSTIC INDICATOR; EAU GUIDELINES; HIGH-RISK; RECURRENCE; MUSCLE; PREDICTS; SURVIVAL;
D O I
10.1016/j.urology.2015.03.036
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To evaluate the influence of tumor diameter and tumor necrosis on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy (RC). MATERIALS AND METHODS We treated 517 consecutive patients with urothelial carcinoma of the bladder treated with RC without neoadjuvant chemotherapy at our institution between 1996 and 2011. All RC specimens were meticulously re-reviewed for the largest residual tumor diameter and for the presence and extent of tumor necrosis. Cox regression models evaluated the association with disease recurrence and cancer-specific survival. RESULTS At RC, 155 patients (30.0%) had a residual tumor diameter >= 3 cm and tumor necrosis was present in 156 patients (30.2%). Tumor diameter and necrosis were significantly correlated (P <. 001). Both a tumor diameter >= 3 cm and the presence of tumor necrosis were associated with an older age, advanced tumor stage, higher tumor grade, lymph node metastasis, positive surgical margin status, lymphovascular invasion, and administration of adjuvant chemotherapy (P values <= .009). A tumor diameter >= 3 cm and the presence of tumor necrosis were associated with disease recurrence and cancer-specific mortality in Kaplan-Meier analyses, respectively (pairwise P values <. 001). In addition, a tumor diameter >= 3 cm was an independent predictor of cancer-specific mortality in multivariate analysis that adjusted for standard clinicopathologic features. CONCLUSION Tumor diameter and necrosis are closely correlated and associated with aggressive tumor features and inferior oncologic outcomes. A residual tumor diameter >= 3 cm is an independent predictor of cancer-specific mortality. This additional information should be considered to be reported in every pathology report for consideration in patient counseling and treatment decision making. In addition, these results underscore the importance of a thorough transurethral resection of the bladder tumor before RC. (C) 2015 Elsevier Inc.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 26 条
[1]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 [J].
Babjuk, Marko ;
Burger, Maximilian ;
Zigeuner, Richard ;
Shariat, Shahrokh F. ;
van Rhijn, Bas W. G. ;
Comperat, Eva ;
Sylvester, Richard J. ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou Redorta, Joan ;
Roupret, Morgan .
EUROPEAN UROLOGY, 2013, 64 (04) :639-653
[2]   Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer [J].
Bochner, Bernard H. ;
Dalbagni, Guido ;
Kattan, Michael W. ;
Fearn, Paul ;
Vora, Kinjal ;
Seo, Hee Song ;
Zoref, Lauren ;
Abol-Enein, Hassan ;
Ghoneim, Mohamed A. ;
Bochner, Bernard H. ;
Dalbagni, Guido ;
Scardino, Peter T. ;
Bajorin, Dean ;
Skinner, Donald G. ;
Stein, John P. ;
Miranda, Gus ;
Gschwend, Juergen E. ;
Volkmer, Bjoern G. ;
Hautmann, Richard E. ;
Chang, Sam ;
Cookson, Michael ;
Smith, Joseph A. ;
Thalman, George ;
Studer, Urs E. ;
Lee, Cheryl T. ;
Montie, James ;
Wood, David ;
Puigvert, Fundacio ;
Palou, Juan ;
Fradet, Yyes ;
LaCombe, Louis ;
Simard, Pierre ;
Schoenberg, Mark P. ;
Lerner, Seth ;
Vazina, Amnon ;
Bassi, PierFrancesco ;
Murai, Masaru ;
Kikuchi, Eiji .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3967-3972
[3]  
Cheng L, 1999, CANCER, V85, P2638, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2638::AID-CNCR21>3.0.CO
[4]  
2-V
[5]   A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability [J].
Chiang, Kun-Chun ;
Lee, Chun-Hui ;
Yeh, Chun-Nan ;
Ueng, Shir-Hwa ;
Hsu, Jun-Te ;
Yeh, Ta-Sen ;
Jan, Yi-Yin ;
Hwang, Tsann-Long ;
Chen, Miin-Fu .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (01) :142-146
[6]  
Droller M J, 2000, J Urol, V163, P665
[7]   The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].
Epstein, JI ;
Amin, MB ;
Reuter, VR ;
Mostofi, FK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448
[8]   Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial [J].
Eustace, Amanda ;
Irlam, Joely J. ;
Taylor, Janet ;
Denley, Helen ;
Agrawal, Shailesh ;
Choudhury, Ananya ;
Ryder, David ;
Ord, Jonathan J. ;
Harris, Adrian L. ;
Rojas, Ana M. ;
Hoskin, Peter J. ;
West, Catharine M. L. .
RADIOTHERAPY AND ONCOLOGY, 2013, 108 (01) :40-47
[9]   A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer [J].
Horn, Lars-Christian ;
Bilek, Karl ;
Fischer, Uta ;
Einenkel, Jens ;
Hentschel, Bettina .
GYNECOLOGIC ONCOLOGY, 2014, 134 (01) :42-46
[10]   HISTOPATHOLOGIC CHANGES OF TRANSITIONAL CELL-CARCINOMA OF BLADDER AFTER M-VAC CHEMOTHERAPY [J].
JAVADPOUR, N ;
DALONI, P .
UROLOGY, 1989, 34 (06) :357-359